This company has been marked as potentially delisted and may not be actively trading. NASDAQ:AMDA Amedica (AMDA) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock Analysis About Amedica Stock (NASDAQ:AMDA) Get Amedica alerts:Sign Up Key Stats Today's Range$2.70▼$2.8450-Day Range$0.09▼$2.1952-Week Range$0.18▼$6.40Volume21,443 shsAverage Volume1.07 million shsMarket Capitalization$32.05 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview SINTX Technologies, Inc. engages in the development and commercialization of silicon nitride for medical and non-medical applications. It markets spinal fusion products and develops products for use in total hip and knee joint replacements. The company was founded by Aaron A. Hofmann and Ashok C. Khandkar in 1996 and is headquartered in Salt Lake City, UT. Read More Receive AMDA Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Amedica and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. AMDA Stock News HeadlinesMexico Plans 50% Tariff on Chinese Cars Before US, Canada TalksSeptember 10, 2025 | msn.comSINTX Technologies (SINT)September 13, 2024 | es.investing.comFederal Reserve Reveals Disturbing New Plan To Control Your MoneyDocket No. OP-1670 is drawing attention for what it reveals about the Federal Reserve's next move. Buried on page 84 is a plan that could expand oversight of checking accounts, purchases, and money transfers across the country. Martin D. Weiss, PhD, founder of Weiss Ratings, breaks down what this document means and why it could roll out as soon as this summer.October 12 at 1:00 AM | Weiss Ratings (Ad)Here's the Best Way for Investors to Play the IPO MarketNovember 5, 2023 | thestreet.comSilicon nitride ceramics Market 2022 | reach USD 683.74 million by 2028 - GlobeNewswireOctober 7, 2022 | globenewswire.comGlobal Interlaminar Device Market to Witness Growth by a CAGR of ~5% throughout 2022 – 2031 Owing to the - BenzingaMarch 27, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 20 - BenzingaFebruary 9, 2022 | benzinga.comGlobal 3D Printed Medical Devices Market Report 2021: Market is Projected to Grow from $1.7 Billion in 2021 to $4.9 Billion by 2026 - GlobeNewswireFebruary 9, 2022 | globenewswire.comSee More Headlines AMDA Stock Analysis - Frequently Asked Questions How were Amedica's earnings last quarter? Amedica Co. (NASDAQ:AMDA) posted its earnings results on Tuesday, November, 21st. The medical equipment provider reported ($0.93) earnings per share for the quarter, beating analysts' consensus estimates of ($0.94) by $0.01. The medical equipment provider earned $2.96 million during the quarter. Amedica had a negative trailing twelve-month return on equity of 148.60% and a negative net margin of 139.62%. When did Amedica's stock split? Amedica's stock reverse split on the morning of Friday, November 10th 2017.The 1-12 reverse split was announced on Friday, November 10th 2017. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, November 9th 2017. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split. What other stocks do shareholders of Amedica own? Based on aggregate information from My MarketBeat watchlists, some other companies that Amedica investors own include Intrepid Potash (IPI), ParkerVision (PRKR), Anavex Life Sciences (AVXL) and GE Aerospace (GE). Company Calendar Last Earnings11/21/2017Today10/12/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Equipment & Supplies Sub-IndustryHealthcare Equipment Current SymbolNASDAQ:AMDA CIK1269026 Webwww.amedica.com Phone(855) 839-3500FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Trailing Twelve Months)($3.13) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$9.32 million Net Margins-139.62% Pretax MarginN/A Return on Equity-148.60% Return on Assets-67.83% Debt Debt-to-Equity RatioN/A Current Ratio1.11 Quick Ratio0.99 Sales & Book Value Annual Sales$11.23 million Price / Sales2.85 Cash FlowN/A Price / Cash FlowN/A Book Value$1.80 per share Price / Book1.50Miscellaneous Outstanding Shares11,870,000Free FloatN/AMarket Cap$32.05 million OptionableNot Optionable Beta-1.24 Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:AMDA) was last updated on 4/8/2026 by MarketBeat.com Staff. From Our PartnersTrump's about to unleash his Midterm WeaponTrump is turning the midterms into a referendum on American energy, pushing for more oil, more gas, and lower ...Monument Traders Alliance | SponsoredUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...Porter & Company | SponsoredHow options let you do more with less capitalWould you rather spend $5,000 buying 100 shares of a $50 stock, or control those same 100 shares for a fractio...Base Camp Trading | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amedica Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Amedica With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free AMDA Stock Alerts